SCHEMBL25629970

SCHEMBL25629970

CCCC[C@@H]1Cc2cc(OC(=O)N3CCC(N4CCCCC4)CC3)ccc2[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 10/20 0.53
ESR2 Q92731 3/20 0.53
HDAC3 O15379 2/20 0.50
HDAC6 Q9UBN7 1/20 0.50
ESRRA P11474 7/20 0.49
ESRRB O95718 6/20 0.49
PGR P06401 2/20 0.45
CYP3A4 P08684 2/20 0.45
CYP2C19 P33261 2/20 0.45
NR1I2 O75469 1/20 0.45
NR3C1 P04150 1/20 0.45
EPHX2 P34913 1/20 0.45
PPARG P37231 1/20 0.45
NR1H4 Q96RI1 1/20 0.45
SIRT5 Q9NXA8 1/20 0.45
CYP1A2 P05177 1/20 0.45
ALOX15 P16050 1/20 0.45
LMNA P02545 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
AR P10275 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26461966 0.97 ESR1 (0.51) ESR1ESR2HDAC3HDAC6ESRRA
SCHEMBL26461999 0.96 ESR1 (0.52) ESR1ESR2HDAC3HDAC6ESRRA
SCHEMBL26461970 0.91 ESR1 (0.51) ESR1ESR2HDAC3HDAC6ESRRA
SCHEMBL26462000 0.90 ESR1 (0.49) ESR1ESR2HDAC3HDAC6ESRRA
SCHEMBL26461984 0.90 ESR1 (0.50) ESR1ESR2HDAC3HDAC6ESRRA
SCHEMBL25630796 0.88 ESR1 (0.44) ESR1ESR2HDAC3HDAC6ESRRA
SCHEMBL23424239 0.88 ESR1 (0.58) ESR1ESR2HDAC3HDAC6ESRRA
SCHEMBL25630794 0.85 ESR1 (0.56) ESR1ESR2HDAC3HDAC6ESRRA
SCHEMBL25630341 0.85 ESR1 (0.43) ESR1ESR2HDAC3HDAC6ESRRA
SCHEMBL26461996 0.85 ESR1 (0.56) ESR1ESR2HDAC3HDAC6ESRRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023105303-A1 COMPOUNDS FOR THE TREATMENT OF CANCER KASHIV BIOSCIENCES, LLC (US) 2023-06-15 WO disclosed